PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 25 filers reported holding PSYCHEMEDICS CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $137,000 | +18.1% | 16,300 | -2.4% | 0.06% | +23.9% |
| Q2 2021 | $116,000 | -12.1% | 16,700 | -21.6% | 0.05% | -16.4% |
| Q1 2021 | $132,000 | +112.9% | 21,300 | +74.6% | 0.06% | +103.7% |
| Q4 2020 | $62,000 | -39.2% | 12,200 | -47.4% | 0.03% | -51.8% |
| Q3 2020 | $102,000 | -1.0% | 23,200 | +24.7% | 0.06% | -6.7% |
| Q2 2020 | $103,000 | -52.1% | 18,600 | +73.8% | 0.06% | +50.0% |
| Q1 2017 | $215,000 | +87.0% | 10,700 | -5.3% | 0.04% | +100.0% |
| Q4 2015 | $115,000 | +3.6% | 11,300 | +2.7% | 0.02% | +5.3% |
| Q3 2015 | $111,000 | – | 11,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 40,001 | $276,000 | 0.13% |
| SANTA MONICA PARTNERS LP | 20,000 | $138,000 | 0.10% |
| Invenomic Capital Management LP | 135,631 | $769,000 | 0.08% |
| Cannell Capital | 78,306 | $540,000 | 0.08% |
| RBF Capital, LLC | 144,231 | $996,000 | 0.06% |
| CRAWFORD INVESTMENT COUNSEL INC | 266,502 | $1,839,000 | 0.04% |
| Ancora Advisors LLC | 80,728 | $557,000 | 0.01% |
| HighMark Wealth Management LLC | 2,039 | $14,000 | 0.01% |
| Renaissance Technologies | 341,422 | $2,356,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 34,618 | $240,000 | 0.00% |